Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints value and access director

Paul Catchpole joins ABPI to promote the value of the industry and improve access to medicines

Paul Catchpole has joined the Association of the British Pharmaceutical Industry (ABPI) to drive the association's work in demonstrating the value of the industry and improving patients' access to innovative medicines.

He joins the association with 26 years' industry experience, most recently as healthcare management director at Roche UK. Paul has been an active member of various ABPI working groups and was also involved in the last two Pharmaceutical Price Regulation Scheme (PPRS) negotiations, influencing the design of patient access and flexible pricing schemes.

Commenting on this new role, Paul said: "I am delighted to be taking up this role at such an important and challenging time for the pharmaceutical industry. The unprecedented economic pressures facing our healthcare system, along with potential political changes, means that the need has never been greater for the industry to be clear about all aspects of value that our medicines bring to patients and the NHS and how these can be evaluated.

"Providing greater and faster access for patients also remains a key challenge and an opportunity where innovative medicines can drive further quality and productivity improvements through strong partnership working with NHS organisations," he added.

Paul takes up his new post on April 26.

19th April 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics